On a molecular level, the enhanced invasive capacity of the tumor cells could be attributed to Blimp-1, showing that Blimp-1 overexpression increased invasion, whereas its knockdown decreased IL-21-mediated tumor cell invasion. The gene discussed is IL21; the disease is neoplasm.